PROGNOSTIC FACTORS IN ASTROCYTOMAS - RELATIONSHIP OF P53, MDM-2, BCL-2 AND PCNA IMMUNOHISTOCHEMICAL EXPRESSION TO TUMOR GRADE AND OVERALL PATIENT SURVIVAL

Citation
J. Ehrmann et al., PROGNOSTIC FACTORS IN ASTROCYTOMAS - RELATIONSHIP OF P53, MDM-2, BCL-2 AND PCNA IMMUNOHISTOCHEMICAL EXPRESSION TO TUMOR GRADE AND OVERALL PATIENT SURVIVAL, Neoplasma, 44(5), 1997, pp. 299-304
Citations number
37
Journal title
ISSN journal
00282685
Volume
44
Issue
5
Year of publication
1997
Pages
299 - 304
Database
ISI
SICI code
0028-2685(1997)44:5<299:PFIA-R>2.0.ZU;2-G
Abstract
The immunohistochemically detected expression of p53, BCL-2, MDM-2 and PCNA proteins in samples of tumor tissues of 42 patients with astrocy tomas or glioblastoma multiforme was statistically compared to degree of malignancy and overall survival. We found relation between p53 prot ein expression and survival in the high grade astrocytomas group (more cases of p53 immunonegative tumors with longer survival), and signifi cantly higher BCL-2 protein expression as well as significantly higher MDM-2 protein expression in the group of low grade astrocytomas. PCNA protein expression showed any relation to tumor grade or survival. De spite the rather small number of samples these results support the hyp othesis that MDM-2 protein may be a potent regulator of functional p53 , expressed in low grade astrocytoma only.